Combined BRAFV600E and MEK Blockade for BRAFV600E-mutant Gliomas

Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-016-2333-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas

Oncotarget
Oncology
2016English

EGFR Blockade Prevents Glioma Escape From BRAFV600E Targeted Therapy

Oncotarget
Oncology
2015English

BRAFV600E Mutation and Papillary Thyroid Cancer—In Reply

JAMA - Journal of the American Medical Association
Medicine
2013English

Vemurafenib for BRAFV600E-positive Metastatic Papillary Thyroid Cancer – Authors' Response

The Lancet Oncology
Oncology
2016English

BrafV600E Cooperates With Pten Loss to Induce Metastatic Melanoma

Nature Genetics
Genetics
2009English

Combined MEK and BCL-XL Inhibition Kills KRAS -Mutant Cells

Cancer Discovery
Oncology
2012English

Lkb1 Loss Promotes Tumor Progression of BRAFV600E-Induced Lung Adenomas

PLoS ONE
Multidisciplinary
2013English

Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients

Oncologist
Cancer ResearchMedicineOncology
2019English

Oncogenic BRAFV600E Governs Regulatory T Cell Recruitment During Melanoma Tumorigenesis

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy